文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

碘对比剂增强直肠水凝胶间隔物用于前列腺癌放疗的CT靶区勾画

Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.
PubMed 文献 · Pract Radiat Oncol · 2019-06-04

该病例系列评估在直肠水凝胶中间加入碘对比剂,使前列腺癌放疗计划不再依赖MRI。3例患者置入改良水凝胶后即刻及1周后行CT,并在一周后行MRI。即刻CT可见间隔物强化(平均122 HU),1周后消失(平均8 HU);2例可评估患者间隔物勾画体积在即刻CT与≥1周MRI间无显著差异(P=.81)。

要点

  • 水凝胶加碘对比剂后即刻CT可见强化,便于勾画直肠前列腺界面
  • 1周后CT强化消失,提示需在置入后早期CT定位
  • 小样本显示CT与MRI勾画间隔物体积无显著差异

核心结论

  • 直肠水凝胶混合碘对比剂后可在CT上显影,并允许勾画其与直肠和前列腺的界面。

研究设计与样本

  • 病例系列纳入3例接受直肠水凝胶间隔物置入并加碘对比剂改良的前列腺癌患者。
  • 置入后1小时内行CT,1周后再次行CT,并在第二次CT时行MRI。
  • 比较CT与MRI之间及配对CT之间的水凝胶勾画。

主要发现

  • 水凝胶置入后即刻CT可见间隔物强化,平均Hounsfield单位为122(范围52-193)。
  • 1周后第二次CT未见强化,平均Hounsfield单位为8(范围-8至29)。
  • 2例患者中,即刻术后CT与≥1周后MRI勾画的间隔物体积无显著差异(患者1:16.6 vs 15.5 cm3;患者2:12.6 vs 14.7 cm3;配对t检验,P=.81)。

关键数值与推荐

  • 即刻CT间隔物平均Hounsfield单位为122(范围52-193)。
  • 1周后CT间隔物平均Hounsfield单位为8(范围-8至29)。
  • 2例患者CT与MRI间隔物体积比较:患者1为16.6 vs 15.5 cm3,患者2为12.6 vs 14.7 cm3,配对t检验P=.81。

临床怎么用

  • 在前列腺癌放疗中,可考虑使用加碘对比剂的直肠水凝胶间隔物,在置入后早期行CT定位以显示间隔物。
  • 该方法可能为MRI不可用或成本受限时提供不依赖MRI的靶区勾画和计划设计替代方案。

局限性

  • 仅纳入3例患者,样本量小。
  • 间隔物勾画体积比较仅在2例患者中进行。
  • 1周后CT强化消失,提示CT显影依赖置入后早期成像。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Hydrogel spacers reduce rectal dose toxicity during prostate cancer radiation therapy. Current products require magnetic resonance imaging (MRI) for visualization during treatment planning, but MRI incompatibility and cost have prompted alternatives using computed tomography (CT). This case series evaluates the addition of iodinated contrast to hydrogel as such an alternative. METHODS AND MATERIALS: Three patients underwent rectal hydrogel spacer placement with iodinated contrast modification. CT was performed within 1 hour of injection and again 1 week later. MRI was obtained at the time of the second CT. Hydrogel delineation was compared between CT and MRI and between paired CT scans. RESULTS: Spacer enhancement was visible on CT immediately after hydrogel placement (mean Hounsfield units, 122; range, 52-193) but not at the second CT 1 week later (mean Hounsfield units, 8; range, -8 to 29). Delineated spacer volume did not significantly differ between immediate postprocedure CT and MRI ≥1 week later in 2 patients (patient 1: 16.6 vs 15.5 cm3; patient 2: 12.6 vs 14.7 cm3; paired t-test, P = .81). CONCLUSIONS: CT visualization of rectal hydrogel admixed with contrast is feasible and allows delineation of interface with rectum/prostate.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Atluri PS, Gannavarapu BS, Timmerman RD, et al. Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer. Pract Radiat Oncol. 2019. PMID: 31173917. doi:10.1016/j.prro.2019.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。